Abstract
Computer-aided drug design (CADD) methodologies have proven to be very effective, greatly enhancing the efficiency of small molecule drug discovery and development processes. These methods include quantitative structureactivity relationship and pharmacophore models, quantitative structure-property relationship models, as well as in silico docking studies. While docking studies very often correctly identify the binding mode of a ligand, they have reduced success in predicting binding affinities. Development of improved and more efficient strategies for scoring binding affinity is a very active area of research. Here we review the utility of computational intelligence approaches such as artificial neural networks, fuzzy logic, and evolutionary computation to the calculation of improved docking scores.
Keywords: Computational intelligence, evolutionary algorithms, artificial neural networks, fuzzy logic, docking scores, in silico docking, high-throughput screening, virtual screening
Current Computer-Aided Drug Design
Title: Computational Intelligence Methods for Docking Scores
Volume: 5 Issue: 1
Author(s): David Hecht and Gary B. Fogel
Affiliation:
Keywords: Computational intelligence, evolutionary algorithms, artificial neural networks, fuzzy logic, docking scores, in silico docking, high-throughput screening, virtual screening
Abstract: Computer-aided drug design (CADD) methodologies have proven to be very effective, greatly enhancing the efficiency of small molecule drug discovery and development processes. These methods include quantitative structureactivity relationship and pharmacophore models, quantitative structure-property relationship models, as well as in silico docking studies. While docking studies very often correctly identify the binding mode of a ligand, they have reduced success in predicting binding affinities. Development of improved and more efficient strategies for scoring binding affinity is a very active area of research. Here we review the utility of computational intelligence approaches such as artificial neural networks, fuzzy logic, and evolutionary computation to the calculation of improved docking scores.
Export Options
About this article
Cite this article as:
Hecht David and Fogel B. Gary, Computational Intelligence Methods for Docking Scores, Current Computer-Aided Drug Design 2009; 5(1) . https://dx.doi.org/10.2174/157340909787580863
DOI https://dx.doi.org/10.2174/157340909787580863 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Need for Nutritious Convenience Foods for the Elderly Population: A Review
Current Nutrition & Food Science Severe Acute Respiratory Syndrome Coronavirus 2 is Penetrating to Dementia Research
Current Neurovascular Research Viral Proteases as Targets for Drug Design
Current Pharmaceutical Design Ethyl Pyruvate: A Novel Treatment for Sepsis
Current Drug Targets Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the Literature
Current Pharmaceutical Design Biomarkers and Osteosarcoma and IGF
Recent Patents on Biomarkers Treatment of Pulmonary Edema by ENaC Activators/Stimulators
Current Molecular Pharmacology Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint
Current Neuropharmacology The Role of Advanced Technologies Supplemented with Traditional Methods in Pharmacovigilance Sciences
Recent Patents on Biotechnology Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review
Current Gene Therapy COVID-19 and Thrombosis: Clinical Aspects
Current Drug Targets Modular Synthesis of New Bicyclic Carbene Precursors
Letters in Organic Chemistry Snake Venom Peptides and Low Mass Proteins: Molecular Tools and Therapeutic Agents
Current Medicinal Chemistry Proteomic Analysis of Neutrophil Priming by PAF
Protein & Peptide Letters Small Molecules in Cancer Therapy: Cytotoxics and Molecularly Targeted Agents
Current Signal Transduction Therapy The Integration of Process R&D in Drug Discovery - Challenges and Opportunities
Combinatorial Chemistry & High Throughput Screening Learning from Bacteriophages - Advantages and Limitations of Phage and Phage-Encoded Protein Applications
Current Protein & Peptide Science Chaperones & Co: Roles in Protein/Nucleic Acid Homeostasis
Current Proteomics Molecular Docking Studies for Protein-Targeted Drug Development in SARS-CoV-2
Letters in Drug Design & Discovery Targeting Infectious Coronavirus Disease 2019 (COVID-19) with Artificial Intelligence (AI) Applications: Evidence Based Opinion
Infectious Disorders - Drug Targets